KatieB 346 Report post Posted May 31, 2016 KRAS Clinical Trial information: This trial is designed to evaluate how safe and effective the study drug known as abemaciclib is in participants with lung cancer. Specifically for people who have a confirmed diagnosis of stage IV non-small cell lung cancer (NSCLC) with a KRAS mutation and who have already received prior chemotherapy. http://www.lillytrialguide.com/juniper3 Quote Share this post Link to post Share on other sites
